The ENVISION project is co-funded by the European Commission under FP7 Grant Agreement N. 241851.
Hadrontherapy is a highly advanced technique of cancer radiotherapy that uses beams of charged particles (ions) to destroy tumour cells.
In order to improve the quality assurance tools for hadrontherapy, the European Commission is funding ENVISION, a 4-year project that aims at developing solutions for: real-time non invasive monitoring, quantitative imaging, precise determination of delivered dose. fast feedback for optimal treatment planning, real-time response to moving organs, simulation studies.
Launched in February 2010, ENVISION is a collaboration of sixteen leading European research centres and industrial partners, coordinated by CERN.
ENVISION also serves as a training platform for the Marie Curie Initial Training Network ENTERVISION.
ENVISION and ENTERVISION are under the umbrella of ENLIGHT, the European Network for Light Ion Hadron Therapy.